Polovin Andrew

TEM CLO Polovin sells 19,092 shares across 3 trades (Feb 19-20) for $1,141,135.85; stock down 10.6% in 30d, 17.0% in 90d; 4 of 4 prior TEM sells well-timed.

Polovin executed 3 separate sales totaling 19,092 shares for $1,141,135.85 over two trading days at an average price of $59.77, reducing his stake by -13.1%. The sale is notable because his prior 4 sales at TEM—all from November 2025—were uniformly well-timed: all 4 showed negative 90-day returns (-20.8%, -22.6%, -23.7%, -24.3%), indicating the insider sold consistently before subsequent declines. The current stock performance is consistent with that pattern: TEM is down 10.6% over 30 days and 17.0% over 90 days from transaction date, and currently trades at $58.37, below the blended sale price of $59.77. Fundamentally, the company remains unprofitable with a net loss of $-79,982,000.00 despite quarterly revenue of $334,206,000.00 and 30.4% annual revenue growth, creating potential tension between growth metrics and operational profitability that may inform insider decisions.

EVP and General Counsel Polovin sold 12,874 shares of TEM at $75.00 (-25.6% from 52-week high); serial selling pattern in past 6 days.

Andrew Polovin, serving as EVP and General Counsel, sold 12,874 shares at $75.00 on 2025-11-24, reducing his holdings by -10.7% from 120,464 to 107,590 shares. This sale occurs within a concentrated selling window: SAME-TICKER HISTORY shows four prior sells on 2025-11-19 and one on 2025-11-18—five distinct transactions in six days totaling an undisclosed cumulative share count. The transaction price of $75.00 is -25.6% below the 52-week high of $103.25, and the stock has declined -13.9% in the past 30 days. Tempus AI remains unprofitable with a net income of $-79,982,000.00 in the latest quarter, though annual revenue growth is +30.4%. The timing of these clustered sales by a senior legal officer, combined with the company's unprofitable status and steep recent price decline, warrants investor scrutiny of the filing and underlying context.

EVP Polovin sells 11,592 shares for $775,833.55 at $66.93 avg; stock now -36.4% from 52-week high.

Andrew Polovin, EVP and General Counsel, executed 6 separate sales totaling 11,592 shares for $775,833.55 at a blended average price of $66.93 on 2025-11-18 and 2025-11-19, reducing his holdings by 8.8% to 120,464 shares. The timing is notable: stock currently trades at $65.69, down 36.4% from its 52-week high of $103.25 and down 26.3% over 30 days, meaning Polovin sold near recent local peaks before the subsequent decline. His cross-ticker track record shows a 55.00% well-timed rate on 20 prior sells, yet at TEM specifically, his 5 prior sales (all on 2025-05-20) were poorly timed—0 of 5 showed declines 90 days after the sale, meaning the stock rose following each transaction. The company remains unprofitable with net income of $-79,982,000.00 despite 30.4% annual revenue growth, creating a backdrop where near-peak selling by an executive with mixed historical timing carries elevated investor attention.

EVP/General Counsel Polovin sells 17.6K shares for $1.1M at blended $63.43; stock down 33.8% from 52-week high.

Andrew Polovin executed 6 separate sales totaling 17,552 shares for $1,113,384.92 on 2025-05-20, reducing his holdings by 11.2% to 138,877 shares. The transactions occurred at prices ranging from $62.19 to $66.05, with a blended average of $63.43, against a current market price of $59.25. At the same-ticker level, Polovin's prior 2 measurable sales (both on 2025-02-19) were well-timed, with 90-day declines of -23.7% and -24.2%; his 3 most recent TEM sales from 2025-03-18 show 30-day declines ranging from -11.6% to -14.6%. The company remains unprofitable (net income of -$68.0M in the latest quarter) despite strong revenue growth of 30.4% year-over-year, suggesting ongoing execution risk. The insider's scale of liquidation—over $1.1M in a single trading day while the stock trades well below its 52-week high—warrants close investor attention given the company's path to profitability remains unproven.

EVP/General Counsel Polovin sells 13,135 shares at $45.98 avg for $603,969.90; holds 154,171 post-transaction as TEM trades at $48.03.

Andrew Polovin, EVP and General Counsel, executed 3 separate sales on 2025-03-18 totaling 13,135 shares for $603,969.90, reducing his holdings by 7.9% to 154,171 shares. The sales occurred at blended average price $45.98, modestly below the current price of $48.03. The company is unprofitable (net income of $-75,840,000) despite revenue growth of +30.4% on a $180,929,000 quarterly revenue base, and the stock is down 46.3% from its 52-week high of $89.44. His cross-ticker track record shows 20 prior sells with 0.00% well-timed rate at the 90-day mark, indicating his past sales have generally not preceded stock declines. At TEM specifically, he has made 5 prior sales (all within the last month), though outcomes remain unmeasurable. This transaction represents routine portfolio activity by an executive at a high-growth but unprofitable company trading well below recent peaks.

EVP & General Counsel Polovin sells 69,932 shares at $82.28 blended average for $5.8M on 2025-02-18/19

Andrew Polovin, EVP and General Counsel, executed 15 separate sales totaling 69,932 shares for $5,754,289.47 across two days, reducing his holdings by 29.5%. The sales occurred at prices ($79.63–$91.00) that are now 6.3–18.7% above the current price of $76.72, and within 7% of the 52-week high of $89.44. His same-ticker history shows five prior sales since December 2024, with 30-day returns ranging from -8.2% to -14.0%, though 90-day outcome data remain incomplete. Against this backdrop, his cross-ticker track record shows an average 30-day return of -11.2% following prior sells, though timing assessment requires longer-term data. The company reported a net loss of $75,840,000.00 on revenue of $180,929,000.00 in the latest quarter, adding fundamental context to a substantial executive liquidation.

EVP and General Counsel Polovin sells 7,717 shares of TEM at $67.57; stock up 83.9% in 30 days but down 11.2% from 52-week high.

Andrew Polovin, EVP and General Counsel, sold 7,717 shares of Tempus AI on 2025-02-05 at $67.57, reducing his holdings from 245.0K to 237.2K shares. The sale follows a month of sharp 83.9% price appreciation, yet occurs well below the 52-week high of $77.62. His prior four trades at Tempus AI (all sales on 2024-12-11) showed negative 30-day returns ranging from -8.2% to -14.0%, establishing a pattern of sales that preceded near-term declines at this ticker. The company reported $180.9M in revenue against a $-75.8M net loss in its latest quarter, indicating ongoing operational challenges. While the timing of this sale relative to a month-long rally may suggest tactical execution, the alignment with his historical pattern of selling into strength—followed by subsequent weakness—warrants investor attention to the company's operational trajectory and whether management continues to view elevated valuations as opportune for liquidation.

Tempus AI EVP Andrew Polovin sells 51,504 shares for $2,183,186.68 as stock down 47.2% from 52-week high

Andrew Polovin, EVP and General Counsel, executed 4 separate sales totaling 51,504 shares for $2,183,186.68 on 2024-12-11 at prices ranging from $40.88 to $43.62, reducing his holdings by 17.3%. The transaction occurred as Tempus AI's stock trades 47.2% below its 52-week high of $77.62 and has declined 39.8% over the prior 30 days. The company reported revenue of $180,929,000.00 against a net loss of $75,840,000.00 in the latest quarter. A C-suite legal officer's substantial liquidation during a period of significant stock depreciation and ongoing losses merits investor scrutiny of the rationale and timing.